Phase 3 Study to Evaluate the Efficacy & Safety of Tralokinumab in Adults & Adolescents With OCS Dependent Asthma
Clinical trial NCT02281357 · COMPLETED
Trial details
- NCT number
- NCT02281357
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-19
- Primary completion
- 2017-09-07
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.